Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06307847 |
| Consolidated Lead Sponsor | Shin Poong Pharmaceutical Co |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 223 participants (ACTUAL) |
| Registered Start Date | 2021-04-14 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Gachon University Gil Medical Center | Incheon, South Korea | Open Hospital Dossier -> |
| Seoul National University Bundang Hospital | Seongnam-si, South Korea | Open Hospital Dossier -> |
| Asan Medical Center | Seoul, South Korea | Open Hospital Dossier -> |
| Chung-Ang University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.